The potential relevance of mitochondrial activities as therapeutic targets in MYC‐driven lymphoma was delineated further by transcriptome analysis across six patient‐derived DLBCL datasets, which revealed a close correlation between MYC‐ and OxPhos‐associated gene expression signatures [292]. The gene discussed is MYC; the disease is lymphoma.